STOCK TITAN

Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Dynavax Technologies Corporation (Nasdaq: DVAX) to present at 42nd Annual J.P. Morgan Healthcare Conference
Positive
  • None.
Negative
  • None.

EMERYVILLE, Calif., Jan. 3, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.

The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.

About Dynavax

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn and Twitter.

For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499

Nicole Arndt
narndt@dynavax.com
510-665-7264

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025790.html

SOURCE Dynavax Technologies

FAQ

When will Dynavax Technologies Corporation present at the 42nd Annual J.P. Morgan Healthcare Conference?

Dynavax Technologies Corporation will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.

Where can I access the webcast of Dynavax Technologies Corporation's presentation at the 42nd Annual J.P. Morgan Healthcare Conference?

The webcast of Dynavax Technologies Corporation's presentation at the 42nd Annual J.P. Morgan Healthcare Conference can be accessed through the 'Events & Presentations' page on the 'Investors' section of the Company's website at https://investors.dynavax.com/events-presentations.

What is the ticker symbol for Dynavax Technologies Corporation?

The ticker symbol for Dynavax Technologies Corporation is DVAX.

Dynavax Technologies Corporation

NASDAQ:DVAX

DVAX Rankings

DVAX Latest News

DVAX Stock Data

1.69B
131.01M
0.34%
104.67%
15.97%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
EMERYVILLE